Enveric Biosciences (ENVB) News Today $2.15 -0.10 (-4.44%) Closing price 05/18/2026 04:00 PM EasternExtended Trading$2.17 +0.02 (+1.16%) As of 05:52 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENVB Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Enveric Biosciences Highlights Positive Results for EB-003 in PTSD Preclinical ModelMay 5, 2026 | businesswire.comLakewood-Amedex Biotherapeutics Appoints Joseph Tucker, Ph.D., to Board of DirectorsApril 28, 2026 | prnewswire.comWhat's going on with Enveric Biosciences stock on Friday?April 24, 2026 | msn.com7 Best Psychedelic Stocks and ETFs to Buy in 2026April 21, 2026 | money.usnews.comEnveric Biosciences Stock Soars After Trump's Psychedelics Executive OrderApril 20, 2026 | benzinga.comEnveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq RulesApril 17, 2026 | financialpost.comFEnveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq RulesApril 17, 2026 | businesswire.comEnveric Biosciences targets up to $13.9M in total proceeds via share and warrant offeringApril 17, 2026 | msn.comENVB stock is on track for its worst decline in over 10 weeks on discounted offering – but retail remains upbeatApril 17, 2026 | msn.comEnveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq RulesApril 16, 2026 | financialpost.comFEnveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq RulesApril 16, 2026 | businesswire.comEnveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025March 27, 2026 | businesswire.comEnveric Biosciences Announces Registration of Five TrademarksMarch 18, 2026 | finance.yahoo.comEnveric Biosciences reports EB-003 receptor engagement assay dataFebruary 20, 2026 | finance.yahoo.comEnveric Biosciences stock soars after revealing new data on lead drug candidateFebruary 19, 2026 | in.investing.comEnveric Biosciences rallies on fresh mechanistic findings for EB-003February 19, 2026 | msn.comEnveric Biosciences Expands At-The-Market Equity Offering CapacityFebruary 6, 2026 | tipranks.comEnveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and OptionJanuary 29, 2026 | financialpost.comFEnveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJanuary 28, 2026 | businesswire.comEnveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJanuary 28, 2026 | finance.yahoo.comEnveric Biosciences announces issuance of U.S. patentDecember 30, 2025 | finance.yahoo.comEnveric Biosciences stock rises after securing patent for novel neurological treatmentsDecember 29, 2025 | investing.comEnveric Biosciences Announces Patent IssuanceDecember 29, 2025 | businesswire.comEnveric Biosciences files to sell 882,627 shares of common stock for holdersDecember 22, 2025 | msn.comEnveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross ProceedsDecember 12, 2025 | businesswire.comEnveric Biosciences announces exercise of warrants for $3.1M gross proceedsDecember 12, 2025 | msn.comEnveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross ProceedsDecember 11, 2025 | businesswire.comEnveric Biosciences stock soars after receiving patent allowanceDecember 10, 2025 | au.investing.comWhy did ENVB stock more than double in value today?December 10, 2025 | msn.comEnveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During "J.P. Morgan Week 2026"December 4, 2025 | finance.yahoo.comEnveric Biosciences Receives Fourth Notice of Allowance for EVM401 Series of Drug CandidatesNovember 26, 2025 | finance.yahoo.comEnveric Biosciences Regains Nasdaq ComplianceNovember 14, 2025 | tipranks.comEnveric Biosciences Reports Third Quarter 2025 Financial and Corporate ResultsNovember 14, 2025 | businesswire.comEnveric Biosciences (ENVB) Price Target Increased by 1,100.00% to 122.40October 30, 2025 | msn.comAbbVie ends in green six straight sessions of declinesOctober 16, 2025 | msn.comEnveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent IssuanceOctober 16, 2025 | businesswire.comEnveric Biosciences to explore digital asset treasury strategy opportunitiesOctober 14, 2025 | msn.comPsychedelic: Enveric announces EB-003 manufacturing milestonesOctober 2, 2025 | msn.comEnveric Biosciences completes key manufacturing milestones for EB-003October 2, 2025 | msn.comEnveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical TrialsOctober 2, 2025 | businesswire.comEnveric Biosciences files to sell 5.02M shares of common stock for holdersSeptember 29, 2025 | msn.comEnveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross ProceedsSeptember 18, 2025 | businesswire.comEnveric Biosciences publishes two peer-reviewed research papersSeptember 17, 2025 | msn.comEnveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross ProceedsSeptember 17, 2025 | businesswire.comEnveric Biosciences receives FDA response, streamlines path for EB-003September 16, 2025 | msn.comEnveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND SubmissionSeptember 16, 2025 | businesswire.comEnveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment ConferenceSeptember 5, 2025 | finance.yahoo.comEnveric Biosciences Releases New Investor PresentationAugust 29, 2025 | tipranks.comEnveric Tanks on Successful TestsAugust 28, 2025 | baystreet.caEnveric Biosciences Announces Preclinical Results Confirming Potential ...August 17, 2025 | businesswire.com Get Enveric Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ENVB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ENVB Media Mentions By Week ENVB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENVB News Sentiment▼0.610.59▲Average Medical News Sentiment ENVB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENVB Articles This Week▼12▲ENVB Articles Average Week Get the Latest News and Ratings for ENVB and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CELU News VYNE News XCUR News TRAW News QNCX News KTTA News LGVN News QNTM News LPCN News ANEB News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENVB) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enveric Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enveric Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
